Venthera, Inc. clinical trials

A subsidiary of BridgeBio

The registry lists 1 studies whose lead sponsor is Venthera, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 4, 2022.

Status

Terminated: 1

Phase

Phase 2: 1
Phase 1: 1

Where

United States: 1

Registry sponsor names on this page

Venthera, Inc., a BridgeBio company1 study

Something wrong with this grouping? Tell us on the BridgeBio page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All BridgeBio studies →

First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene MutationsTerminatedNCT04409145Phase 1/2
Sponsor listed in the registry: Venthera, Inc., a BridgeBio company